未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer曲妥珠单抗Deruxtecan在早期乳腺癌残留HER2-Positive中的应用
Loibl, Sibylle; Park, Yeon Hee; Shao, Zhiming; Huang, Chiun-Sheng; Barrios, Carlos; Abraham, Jame; Prat, Aleix; Niikura, Naoki; Im, Seock-Ah; Li, Wei; Li, Huiping; Wang, Yongsheng; Yao, Herui; Kim, Sung-Bae; Geng, Cui-zhi; Rodriguez Pantigoso, Wuilbert; Ramirez Godinez, Francisco Javier; Song, Chuangui; Ching Chang, Yuan; Antoniazzi, Augusto; Chen, Shin-Cheh; Li, Zhigao; Nowecki, Zbigniew; Lim, Joline; Mathias, Elton; Sato, Yuta; Lu, Wenjing; Abdel-Monem, Hanan; Untch, Michael; Geyer, Charles E. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trialKN026和多西他赛治疗HER2阳性乳腺癌的疗效与安全性：一项II期临床试验Ma, Jianli; Wang, Jingxuan; Xu, Ting; Ouyang, Quchang; Wang, Xiaojia; Wang, Jingfen; Gan, Lu; Ouyang, Zhong; Lin, Daren; Sun, Tao; Shan, Changping; Yao, Herui; Zhang, Baochun; Li, Zhengguang; Zhuang, Zhixiang; Lu, Ying; Yang, Hongwei; Huang, Jian; Yang, Xingwang; Sun, Hongmei; Zhang, Qingyuan 分享 收藏 Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy AssessmentI期临床试验：Upamostat联合吉西他滨治疗局部不可切除或转移性胰腺癌：安全性及初步疗效评估Lai, Xiuping; Cheng, Di; Xu, Huixin; Wang, Jingshu; Lv, Xiaozhi; Yao, Herui; Li, Liuning; Wu, Junyan; Ye, Suiwen; Li, Zhihua 分享 收藏 Multi-center, retrospective GUIDANCE001 trial comparing TACE with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages多中心、回顾性GUIDANCE001试验：比较转化治疗中肝动脉化疗栓塞术（TACE）联合或不联合酪氨酸激酶抑制剂和免疫检查点抑制剂治疗不可切除肝癌的生存获益——在进展期或中晚期但非早期患者中。Yang, D.; Zeng, F-J.; Nong, J-L.; Liu, J.; Yao, H-B.; Ye, L.; Peng, N.; Li, W-F.; Wu, P-S.; Qin, C.; Su, Z.; Ou, J-J.; Dong, X-F.; Yan, Y-H.; Zhong, T-M.; Wu, M-S.; Chen, Y-Z.; Wang, G-D.; Ma, L.; Zhong, J-H. 分享 收藏 分享 收藏 Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trialLiu, Guo-Ying; Ye, Yan-Fang; Jiang, Yao-Fei; Chen, Gina Jinna; Xia, Wei-Xiong; Huang, Yi-Sheng; Gao, Tian-Sheng; Liu, Yi-Min; Hou, Ya-Ting; Li, Jian-Fei; Liu, Jia-Hao; Lu, Nian; Chen, Chang-Long; Ke, Liang-Ru; Liang, Hu; Bei, Wei-Xin; Li, Wang-Zhong; Dong, Shu-Hui; Liu, Qin; Xie, Changqing; Yao, He-Rui; Xiang, Yan-Qun 分享 收藏 Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapyChen, Haizhu; Gui, Xiujuan; Zhou, Ziwei; Su, Fengxi; Gong, Chang; Li, Shunrong; Wu, Wei; Rao, Nanyan; Liu, Qiang; Yao, Herui 分享 收藏 Deep learning-based multi-modal data integration enhancing breast cancer disease-free survival prediction基于深度学习的多模态数据整合增强乳腺癌无病生存预测Wang, Zehua; Lin, Ruichong; Li, Yanchun; Zeng, Jin; Chen, Yongjian; Ouyang, Wenhao; Li, Han; Jia, Xueyan; Lai, Zijia; Yu, Yunfang; Yao, Herui; Su, Weifeng 分享 收藏 Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer人工智能可实现宫颈细胞学分级和宫颈癌的精确诊断Wang, Jue; Yu, Yunfang; Tan, Yujie; Wan, Huan; Zheng, Nafen; He, Zifan; Mao, Luhui; Ren, Wei; Chen, Kai; Lin, Zhen; He, Gui; Chen, Yongjian; Chen, Ruichao; Xu, Hui; Liu, Kai; Yao, Qinyue; Fu, Sha; Song, Yang; Chen, Qingyu; Zuo, Lina; Wei, Liya; Wang, Jin; Ouyang, Nengtai; Yao, Herui 分享 收藏 BL-M07D1, an antibody- drug conjugate directed to HER2 in patients with locally advanced or metastatic Breast Cancer with HER2-positive/low-expression and other solid tumors: Results from a first-in-human phase 1 studySong, Erwei; Yao, Herui; Sun, Meili; Zong, Hong; Lin, Rongbo; Zou, Wen; Ding, Muran; Yu, Jing; Xiao, Sa; Wang, Hongwei; Zhu, Hai; Olivo, Martin; Zhu, Yi 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
